. Baskıdaki Makaleler: TJH-51436 | DOI: 10.4274/tjh.galenos.2024.2024.0101 | |||
Elif Gülsüm Ümit1, Ahmet Muzaffer Demir1, Muhlis Cem Ar2, Mesut Ayer3, Meltem Aylı4, Volkan Karakuş5, Emin Kaya6, Fahir Özkalemkaş7, Nilgün Sayınalp8, Mehmet Sönmez9, Fahri Şahin10, Selami Koçak Toprak11, Tayfur Toptaş12, İrfan Yavaşoğlu13, Ümran Çalış141Trakya University Faculty of Medicine, Division of Hematology, Edirne, Türkiye 2İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Division of Hematology, İstanbul, Türkiye 3University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Hematology, İstanbul, Türkiye 4University of Health Sciences Türkiye, Gülhane Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye 5University of Health Sciences Türkiye, Antalya Training and Research Hospital, Clinic of Hematology, Antalya, Türkiye 6İnönü University Faculty of Medicine, Division of Hematology, Malatya, Türkiye 7Bursa Uludağ University Faculty of Medicine, Division of Hematology, Bursa, Türkiye 8Hacettepe University Faculty of Medicine, Division of Hematology, Ankara, Türkiye 9Karadeniz Technical University Faculty of Medicine, Division of Hematology, Trabzon, Türkiye 10Ege University Faculty of Medicine, Division of Hematology, İzmir, Türkiye 11Ankara University Faculty of Medicine, Division of Hematology, Ankara, Türkiye 12Marmara University Faculty of Medicine, Division of Hematology, İstanbul, Türkiye 13Aydın Adnan Menderes University Faculty of Medicine, Division of Hematology, Aydın, Türkiye 14Abdi İbrahim İlaç Sanayi ve Tic. A.Ş. Senior Medical Manager, İstanbul, Türkiye Amaç: Giriş: Primer immün trombositopeni, trombositlerin karmaşık ve tam aydınlanmamış bir mekanizma ile artmış immün yıkım ya da azalmış yapımına bağlı olarak azaldığı edinsel bir hastalıktır. ITP tedavisi gelişmek ile birlikte, gebelik, acil durumlar ve ek tedavi gereksinimi gibi özel durumların yönetimi için rehberlere ihtiyaç vardır. Çalışmamızdaki amaç, Türkiye’deki hematologların bu özel durumlara yaklaşımını belirlemektir. Management of Primary Immune Thrombocytopenia – Turkish Modified Delphi-Based Consensus Statement for Special ConsiderationsElif Gülsüm Ümit1, Ahmet Muzaffer Demir1, Muhlis Cem Ar2, Mesut Ayer3, Meltem Aylı4, Volkan Karakuş5, Emin Kaya6, Fahir Özkalemkaş7, Nilgün Sayınalp8, Mehmet Sönmez9, Fahri Şahin10, Selami Koçak Toprak11, Tayfur Toptaş12, İrfan Yavaşoğlu13, Ümran Çalış141Trakya University Faculty of Medicine, Division of Hematology, Edirne, Türkiye2İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Division of Hematology, İstanbul, Türkiye 3University of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Hematology, İstanbul, Türkiye 4University of Health Sciences Türkiye, Gülhane Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye 5University of Health Sciences Türkiye, Antalya Training and Research Hospital, Clinic of Hematology, Antalya, Türkiye 6İnönü University Faculty of Medicine, Division of Hematology, Malatya, Türkiye 7Bursa Uludağ University Faculty of Medicine, Division of Hematology, Bursa, Türkiye 8Hacettepe University Faculty of Medicine, Division of Hematology, Ankara, Türkiye 9Karadeniz Technical University Faculty of Medicine, Division of Hematology, Trabzon, Türkiye 10Ege University Faculty of Medicine, Division of Hematology, İzmir, Türkiye 11Ankara University Faculty of Medicine, Division of Hematology, Ankara, Türkiye 12Marmara University Faculty of Medicine, Division of Hematology, İstanbul, Türkiye 13Aydın Adnan Menderes University Faculty of Medicine, Division of Hematology, Aydın, Türkiye 14Abdi İbrahim İlaç Sanayi ve Tic. A.Ş. Senior Medical Manager, İstanbul, Türkiye Objective: Introduction: Primary immune thrombocytopenia (ITP) is an acquired disorder of platelets with complex and unclear mechanism of increased immune distruction or impaired production of platelets. While management of ITP is evolving, there is a need for guidance particularly in certain circumstances such as pregnancy, emergency and for patients requiring councorrected proof medications. We aimed to determine the tendencies of hematologists in Turkiye on such special conditions. Sorumlu Yazar: Elif Gülsüm Ümit |
|